SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantirs rally to fresh highs is drawing attention after bullish analyst upgrades, including Goldman Sachs Buy rating, which cited opportunities in sovereign AI and customized software. Bulls are celebrating the breakout and pushing back on bearish bets, while skeptics argue the valuation is stretched and warn of a pullback.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas Nasdaq-100 reentry, bringing index-fund buying, and a planned NIH cancer-vaccine initiative are driving attention, alongside optimism about its Merck-partnered melanoma vaccine and upcoming clinical data. Bulls see momentum in the oncology opportunity, while bears argue the rally is outpacing fundamentals and may fade as index-related buying ends.

Polkadot is a platform that allows diverse blockchains to transfer messages, including value, in a trust-free fashion; sharing their unique features while pooling their security. In brief, Polkadot is a scalable heterogeneous multi-chain technology.  Polkadot is heterogeneous because it is entirely flexible and makes no assumption about the nature or structure of the chains in the network. Even non-blockchain systems or data structures can become parachains if they fulfill a set of criteria.  Polkadot may be considered equivalent to a set of independent chains (e.g. a set containing Ethereum, Ethereum Classic, Namecoin and Bitcoin) except with important additions: pooled security and trust-free interchain transactability.  Many of the native parachains of Polkadot will be written using a Polkadot Runtime Environment SDK (e.g. Parity Technologies' Substrate).

Polkadot

DOTs sharp rebound from recent lows is driving attention, with traders pointing to technical buying and the proposed dotUSD stablecoin and tokenomics changes as possible supporting narratives. Bullish traders see a recovery taking shape, while skeptics argue the move may be a short-lived bounce amid Polkadots prolonged decline.

Fundrise Innovation Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

Anticipation of a potential Anthropic IPO is driving interest in VCX as a private-AI investment proxy, with traders also pointing to other private holdings such as OpenAI and Anduril. The debate centers on lockup-related share supply and whether VCXs market price is justified by its estimated NAV: bears see further pressure, while bulls expect IPO-related interest to support the fund.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

Attention centers on upcoming clinical readouts for zugo-cel in systemic sclerosis and CTX310 in severe hypertriglyceridemia, seen as important tests of CRSPs autoimmune and in-vivo cardiovascular programs. Bulls hope the data will change the stocks prolonged trading pattern, while skeptics question whether positive results will lead to a sustained move.

Marathon Petroleum Corp. engages in the refining, marketing, and transportation of petroleum products. It operates through the Refining and Marketing, and Midstream segments. The Refining and Marketing segment includes refining crude oil and other feedstocks, purchasing ethanol, and refined products for resale and distribution of refined products. The Midstream segment refers to transportation, storing, distribution, and marketing of crude oil and refined products. The company was founded in 1887 and is headquartered in Findlay, OH.

Marathon Petroleum Corp

MPC is drawing attention as traders focus on tight refined-fuel supply and elevated diesel crack spreads, which they see as supporting refining margins and the stocks run to record highs. Some remain bullish on the margin backdrop, while others point to profit-taking, stretched valuations, and the risk that margins could cool.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum CEO Michael Hurlstons comments that optical components are sold out through early 2029, with supply unable to meet demand for some products, have focused attention on AI data-center demand and lifted shares to fresh highs. Traders are bullish on the demand signal, while others argue capacity constraints could limit growth and say the stock is overextended or richly valued.

Valero Energy Corp. engages in the manufacture and marketing of transportation fuels and other petrochemical products. It operates through the following business segments: Refining, Ethanol and Renewable Diesel. The Refining segment consists of refining operations, associated marketing activities, and logistics assets that support its refining operations. The Ethanol segment includes its ethanol operations, associated marketing activities, and logistics assets that support its ethanol operations. The Renewable Diesel covers the operations of Diamond Green Diesel Holdings LLC. The company was founded in 1980 and is headquartered in San Antonio, TX.

Valero Energy Corp.

VLO is drawing attention as tight diesel supplies and unusually strong refining crack spreads support expectations for elevated refinery margins amid geopolitical disruptions. Traders remain divided between the strong refining-fundamentals and breakout case and concerns about profit-taking, stretched valuations, and possible diesel-export restrictions that could pressure margins.

Take-Two Interactive Software, Inc. engages in the development, publishing, and marketing of interactive software games. Its products are designed for console systems, handheld gaming systems, and personal computers, including smart phones and tablets, and are delivered through physical retail, digital download, online platforms, and cloud streaming services. The company was founded by Ryan A. Brant in 1993 and is headquartered in New York, NY.

Take-Two Interactive Software, Inc.

Anticipation for Grand Theft Auto VIs scheduled launch is the dominant focus, with bullish traders expecting blockbuster sales and a build-up in demand. Skeptics argue the hype is already reflected in the stock and point to uncertainty around the online mode and its monetization, while recent leaks and game reveals have fueled debate over why the enthusiasm has not translated into stronger share performance.

T-Mobile US, Inc. engages in the provision of wireless communications services under the T-Mobile and MetroPCS brands. It offers postpaid and prepaid wireless voice, messaging and data services, and wholesale wireless services. The company was founded in 1994 and is headquartered in Bellevue, WA.

T-Mobile US Inc

SpaceXs planned acquisition of low-band spectrum to expand Starlink Mobile has raised fears of a future competitor to T-Mobile and contributed to a sharp selloff in wireless shares. Traders are divided between seeing a long-term competitive threat and viewing the reaction as an overreaction, arguing that building a capable terrestrial network will take substantial time and investment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ABCL felt like an idiot adding yesterday, maybe it will pay off?

Ztirf

Adam DeMamp

Christer

StockTwits Web

AbCellera Biologics Inc

 felt like an idiot adding yesterday, maybe it will pay off?

Gatsby

StockTwits For Android 

StockTwits for iOS

@TraderinNYC Patience     it will be good    dont worry

 Patience     it will be good    dont worry